History

Company Founder:
Eikuma Koba

Eikuma Koba signed an agreement with Mulford Laboratories in the US, founding Maruho Shoten in the Doshomachi area of Osaka

Maruho
Shoten(1920)

Maruho Shoten became a limited partnership

Contract signed with DR. KADE Pharmazeutische Fabrik GmbH, a German pharmaceutical manufacturer, making Maruho exclusive distributor in Japan

Name changed to Maruho Shoten Co., Ltd.

Maruho was merged with Wakyo Pharmaceuticals by government order

Maruho Shoten Co., Ltd. re-established on October 13

Import / marketing contract with Luitpold-Werk Chemischpharmazeutische Fabrik

Oyodo Research Laboratories set up （active until 1972）

Oyodo Plant completed （active until 1967）

Current name adopted: Maruho Co., Ltd.

Shin-Oyodo Plant completed （active until 1972）

Hikone Plant completed.

Hikone Plant completed, Shin-Oyodo Plant renovated and became Oyodo Research Laboratories（active until 1998）

Munich Representative Office established（active until 2006）

Head office moved to the current location in Osaka

Drug Development
Laboratories

Established Central Research and Development Laboratories （the current Kyoto R&D Center Drug Development Laboratories） in Kyoto, to include all Maruho laboratories

Announced Long-Term Vision 2002, "Global Boutique Company for Dermatology"

Established Maruho UK Office in Edinburgh （active until 2003）

Drug Discovery Research
Laboratories

Established Drug Discovery Research Laboratories at the Kyoto R&D Center

Opened London Office （active until 2012）

Opened Düsseldorf Representative Office (active until 2013)

Opened Tokyo Development Office

Opened New York Office（active until 2011）

Nagahama Plant completed

Announced Long-Term Vision 2011, "Excellence in Dermatology"

Established Maruho North America Inc. (MNAI) as a wholly owned subsidiary (active until 2015)

Acquired Cutanea Life Sciences, Inc. (Cutanea) in the US as a wholly owned subsidiary

Established Maruho Europe Ltd. (MEL) as a wholly owned subsidiary (active until 2015)

Established Maruho Deutschland GmbH as a wholly owned subsidiary

Acquired Maruho Hatsujyo Kogyo Co., Ltd. as a subsidiary through share acquisition

Established Tateyama Pharmaceutical Factory Co., Ltd. as a subsidiary

Integrated MNAI into Cutanea (active until 2019)

Established the Maruho Takagi Dermatology Foundation. (From August it was certified as a Public Interest Incorporated Foundation by the Japanese Government)

Established Maruho America Inc. (MAI) as a wholly owned subsidiary

Established Maruho Shonan Innovation Lab (MSiL) as a New Research Base

Acquired Roman Industries Co., Ltd. as a subsidiary through share acquisition